BIOXYTRAN, INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bioxytran, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
  • Bioxytran, Inc Operating Income (Loss) for the quarter ending December 31, 2024 was -$484K, a 52% increase year-over-year.
  • Bioxytran, Inc Operating Income (Loss) for the twelve months ending December 31, 2024 was -$2.22M, a 41.5% increase year-over-year.
  • Bioxytran, Inc annual Operating Income (Loss) for 2024 was -$2.22M, a 41.5% increase from 2023.
  • Bioxytran, Inc annual Operating Income (Loss) for 2023 was -$3.8M, a 56% decline from 2022.
  • Bioxytran, Inc annual Operating Income (Loss) for 2022 was -$2.44M, a 42.2% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$2.22M -$484K +$523K +52% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-03
Q3 2024 -$2.75M -$346K +$639K +64.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$3.39M -$609K +$448K +42.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$3.83M -$784K -$33.5K -4.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-19
Q4 2023 -$3.8M -$1.01M +$87.6K +8.01% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-03
Q3 2023 -$3.89M -$985K -$1M -7028% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$2.89M -$1.06M -$520K -96.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$2.37M -$750K +$68.9K +8.41% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-19
Q4 2022 -$2.44M -$1.09M -$158K -16.9% Oct 1, 2022 Dec 31, 2022 10-K/A 2025-01-13
Q3 2022 -$2.28M $14.2K +$561K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$2.84M -$537K +$505K +48.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-31
Q1 2022 -$3.34M -$819K +$870K +51.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$4.21M -$936K -$160K -20.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$4.05M -$547K -$433K -378% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$3.62M -$1.04M -$930K -831% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$2.69M -$1.69M -$1.42M -535% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q4 2020 -$1.27M -$776K -$231K -42.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$1.04M -$114K +$736K +86.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
Q2 2020 -$1.77M -$112K -$5.41K -5.08% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$1.77M -$266K -$136K -105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$1.63M -$545K -$378K -227% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-09
Q3 2019 -$1.25M -$850K -$803K -1689% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$450K -$106K -$106K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$344K -$130K -$129K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$215K -$167K -$80.2K -92.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$135K -$47.5K -$98.4K -193% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$36.5K -$275* +$258K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$295K -$670* +$62K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$357K -$86.4K -$224K -163% Oct 5, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$133K $50.8K +$263K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$396K -$258K -$115K -80.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$281K -$62.6K +$390K +86.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$671K $137K +$250K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$921K -$212K -$184K -653% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$738K -$143K +$1.77M +92.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$2.51M -$453K -$416K -1118% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$2.09M -$113K +$63.1K +35.8% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$2.16M -$28.2K +$1.09M +97.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-09
Q2 2015 -$3.24M -$1.91M -$1.86M -3308% Apr 1, 2015 Jun 30, 2015 10-Q 2016-09-20
Q1 2015 -$1.38M -$37.2K -$103K -157% Jan 1, 2015 Mar 31, 2015 10-Q 2016-09-20
Q4 2014 -$1.28M -$176K -$83.1K -89.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-09-20
Q3 2014 -$1.2M -$1.11M -$839K -305% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$358K -$56.2K +$575K +91.1% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$934K $65.8K +$1.04M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q4 2013 -$1.97M -$92.9K +$569K +86% Oct 1, 2013 Dec 31, 2013 10-K 2015-04-10
Q3 2013 -$2.54M -$275K +$211K +43.4% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$2.75M -$632K +$33.4K +5.02% Mar 31, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$2.79M -$973K -$497K -104% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$2.29M -$662K +$1.9M +74.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-14
Q3 2012 -$4.19M -$486K -$138K -39.7% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$4.05M -$665K -$533K -403% Mar 31, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$3.52M -$476K +$910K +65.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$4.43M -$2.56M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-15
Q3 2011 -$348K -$278K -399% Jul 1, 2011 Sep 30, 2011 10-Q/A 2012-12-31
Q2 2011 -$132K -$11.7K -9.73% Apr 1, 2011 Jun 30, 2011 10-Q/A 2013-01-22
Q1 2011 -$1.39M Jan 1, 2011 Mar 31, 2011 10-Q/A 2013-01-22
Q3 2010 -$69.8K Jul 1, 2010 Sep 30, 2010 10-Q/A 2012-12-31
Q2 2010 -$121K Apr 1, 2010 Jun 30, 2010 10-Q/A 2012-12-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.